Heparin-induced thrombocytopenia in a renal transplant recipient

American Journal of Transplantation

Volumn 5, Issue 6, 2005, Pages 1537-1540

  Anderegg, Brent A ^a   Baillie, G Mark ^a,b   Lin, Angello ^b   Lazarchick, John ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Direct thrombin inhibitor; Heparin induced thrombocytopenia; Thrombosis; Transplantation

Indexed keywords

ARGATROBAN; CALCINEURIN INHIBITOR; HEPARIN; HIRULOG; LEPIRUDIN; THYMOCYTE ANTIBODY; WARFARIN;

ADULT; ARTERY THROMBOSIS; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; EVALUATION; GRAFT SURVIVAL; HEPARINIZATION; HIGH RISK PATIENT; HUMAN; KIDNEY TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOSIS; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; GRAFT SURVIVAL; HEPARIN; HUMANS; KIDNEY TRANSPLANTATION; MALE; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; THROMBOCYTOPENIA;

EID: 20544469383     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00828.x     Document Type: Article

References (21)

1. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996; 101: 502-507.
2. Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia, 2nd Ed., New York: Marcel Dekker, Inc., 2001: 1-18.
3. Warkentin TE, Levine MN, Hirsh J. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335.
4. Warkentin TE, Sheppard JI, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 1999; 96: 1703-1708.
5. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003; 76: 2121-2131.
6. Francis JL, Palmer GJ, Moroose R, Drexler A. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Ann Thorac Surg 2003; 75: 17-22.
7. Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 2003; 163: 2518-2524.
8. Broughan TA, Kottke-Marchant K, Vogt DP. The "white clot syndrome" in hepatic transplantation. Transplantation. 1996; 61: 982-984.
9. PF4 Enhanced®. [Package Insert]. Waukesha, WI: GTI, 2004.
10. Argatroban [package insert]. Research Triangle Park, NC: Glaxo-SmithKline, 2003.
11. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344: 1286-1292.
12. Walenga JM, Jeske WP, Fasanella AR, Wood JJ, Bakhos M. Laboratory tests for the diagnosis of heparin-induced thrombocytopenia. Semin Thromb Hemost 1999; 25: 43-49.
13. Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse B, Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbant assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1999; 111: 700-706.
14. Refludan® [package insert], Wayne, NJ: Berlex Laboratories, 2002.
15. Angiomax® [package insert]. Parsippany, NJ: The Medicines Company, 2003.
16. Bott JN, Reddy K, Krick S. Bivalirudin use in off-pump myocardial revascularization in patients with heparin-induced thrombocytopenia. Ann Thorac Surg 2003; 76: 273-275.
17. Weitz JI, Hirsh J. New anticoagulant drugs. Chest 2001; 119(Suppl.):95S-107S.
18. Gosselin RC, Dager WE, King JH et al. Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values. Am J Clin Pathol 2004; 121: 593-599.
19. Thymoglobulin® [package insert]. Cambridge, MA: Genzyme Corporation, 2004.
20. Trivedi HS, Lal SM, Gupta N, Ross G. Atgam associated coagulopathy in renal transplant patients: a report of two unusual cases. Int J Artif Organs 1996; 19: 448-450.
21. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.